Release Studies on Ciprofloxacin Loaded Non-ionic Surfactant Vesicles
暂无分享,去创建一个
[1] Nikhil Biswas,et al. Nonionic Surfactant Vesicles in Ocular Delivery: Innovative Approaches and Perspectives , 2014, BioMed research international.
[2] H. Abdelkader,et al. Effects of surfactant type and cholesterol level on niosomes physical properties and in vivo ocular performance using timolol maleate as a model drug , 2014, Journal of Pharmaceutical Investigation.
[3] A. Pardakhty,et al. Nano-niosomes in drug, vaccine and gene delivery: a rapid overview , 2013 .
[4] Azza A. Hasan,et al. Formulation and evaluation of metformin hydrochloride-loaded niosomes as controlled release drug delivery system , 2013, Drug delivery.
[5] A. Pardakhty,et al. Ciprofloxacin nano-niosomes for targeting intracellular infections: an in vitro evaluation , 2013, Journal of nanoparticle research.
[6] S. Chaudhari,et al. Niosomes: novel sustained release nonionic stable vesicular systems--an overview. , 2012, Advances in colloid and interface science.
[7] S. Moghim,et al. Comparison of Epothilone and Taxol Binding in Yeast Tubulin using Molecular Modeling , 2011, Avicenna journal of medical biotechnology.
[8] R. Alany,et al. Design and evaluation of controlled-release niosomes and discomes for naltrexone hydrochloride ocular delivery. , 2011, Journal of pharmaceutical sciences.
[9] Z. Drulis-Kawa,et al. Liposomes as delivery systems for antibiotics. , 2010, International journal of pharmaceutics.
[10] O. Sammour,et al. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. , 2008, International journal of pharmaceutics.
[11] J. Gubernator,et al. IN VITRO ANTIMICROBIAL ACTIVITY OF LIPOSOMES CONTAINING CIPROFLOXACIN, MEROPENEM AND GENTAMICIN AGAINST GRAM-NEGATIVE CLINICAL BACTERIAL STRAINS , 2007 .
[12] A. Pardakhty,et al. In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin. , 2007, International journal of pharmaceutics.
[13] A. Pardakhty,et al. Caffeine-Loaded Niosomes: Characterization and in Vitro Release Studies , 2007, Drug delivery.
[14] Rania M. Hathout,et al. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. , 2005, International journal of pharmaceutics.
[15] Richard A. Durst,et al. Liposome encapsulation of fluorescent nanoparticles: Quantum dots and silica nanoparticles , 2005 .
[16] J. Knuuti,et al. Efficacy of Ciprofloxacin-Releasing Bioabsorbable Osteoconductive Bone Defect Filler for Treatment of Experimental Osteomyelitis Due to Staphylococcus aureus , 2005, Antimicrobial Agents and Chemotherapy.
[17] J. Hernández-Borrell,et al. Does ciprofloxacin interact with neutral bilayers? An aspect related to its antimicrobial activity. , 2003, International journal of pharmaceutics.
[18] A. Pardakhty,et al. Development and Physical Characterization of Sorbitan Monoester Niosomes for Insulin Oral Delivery , 2003, Drug delivery.
[19] K. Li,et al. Studies on a high encapsulation of colchicine by a niosome system. , 2002, International journal of pharmaceutics.
[20] C. Oliphant,et al. Quinolones: a comprehensive review. , 2002, American family physician.
[21] O. Lorenzetti,et al. Ocular bioavailability of ciprofloxacin in sustained release formulations. , 2001, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.
[22] L. Peltonen. The Interfacial Behaviour of Sorbitan Surfactant Monolayers and the Bulk Properties of These Surfactants as a Function of Temperature , 2001 .
[23] J. Hadgraft,et al. Topical delivery of caffeine from some commercial formulations. , 1999, International journal of pharmaceutics.
[24] F. Bonini,et al. Ciprofloxacin-loaded polyisobutylcyanoacrylate nanoparticles: pharmacokinetics and in vitro antimicrobial activity , 1998 .
[25] Y. Oh,et al. Formulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infection , 1995, Antimicrobial agents and chemotherapy.
[26] A. Florence,et al. Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60 and 80) and a sorbitan triester (Span 85) , 1994 .
[27] A. Mitra,et al. Pharmacodynamics of Insulin Following Intravenous and Enteral Administrations of Porcine-Zinc Insulin to Rats , 1992, Pharmaceutical Research.
[28] J. Gier,et al. Lipid composition and permeability of liposomes. , 1968, Biochimica et biophysica acta.
[29] S. Kumar,et al. VESICULAR SYSTEMCARRIER FOR DRUG DELIVERY , 2011 .
[30] A. Jha,et al. Vesicular System-Carrier for Drug Delivery , 2011 .
[31] P. Luo,et al. Synthesis and characterization of hydroxyapatite-ciprofloxacin delivery systems by precipitation and spray drying technique , 2008, AAPS PharmSciTech.
[32] C. Cable. An examination of the effect of surface modifications on the physicochemical and biological properties of non-ionic surfactant vesicles , 1990 .
[33] D. Maurice,et al. The influence of non-ionic detergents and other surfactants on human corneal permeability. , 1971, Experimental eye research.